In the published article, there was an error in the Funding statement. The source and funding of the Genome Sequencing data of the African-American participants were inaccurately reported.
The correct Funding statement appears below.
Funding Statement
This work was funded by the Swedish Heart-Lung Foundation awarded to NR (grant nos. 20170664, 20200505, and 20200506), SK (grant no. 20200163), and JG (grant no. 20190478); Karolinska Institutet Foundation awarded to NR (grant no. FS-2018:0007); and Swedish Research Council awarded to LP (grant no. 2018-02884) and JG (grant no. 2019-01034). This work was also funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through grant FI 1935/1-1. The work received further infrastructure support from the DFG under Germany's Excellence Strategy—EXC 2167-390884018 and the PopGen Biobank (Kiel, Germany; Ref Nr. 2018-032). The popgen 2.0 network (P2N) was supported by a grant from the German Federal Ministry of Education and Research (01EY1103). The US-AA sarcoidosis data and specimen collection are derived from the Trans-Omics in Precision Medicine (TOPMed) program was supported by the National Heart, Lung and Blood Institute (NHLBI). Genome Sequencing for “NHLBI TOPMed: African-American Sarcoidosis Genetics Resource” (phs001207.v3.p1) was performed at Baylor College of Medicine Human Genome Sequencing Center (3R01HL113326-04S1); Northwest Genomics Center (HHSN268201600032I); and Broad Institute Genomics Platform (HHSN268201600034I). Core support including centralized genomic read mapping and genotype calling, along with variant quality metrics and filtering were provided by the TOPMed Informatics Research Center (3R01HL-117626-02S1; contract HHSN268201800002I). Core support including phenotype harmonization, data management, sample-identity QC, and general program coordination were provided by the TOPMed Data Coordinating Center (R01HL-120393; U01HL-120393; contract HHSN268201800001I). We gratefully acknowledge the studies and participants who provided biological samples and data for TOPMed. The US-AA cohort investigators are funded via grants from the Foundation for Sarcoidosis Research (Chicago, IL) and the National Institutes of Health (R01HL113326, P30 GM110766, and U54GM104938-06). The computations and genomic data handling were enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) at the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX), partially funded by the Swedish Research Council through grant agreement no. 2018-05973.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.